- Login
- Register & Subscribe
- Langue: EN FR DE
Regenerative Medicine
ECJ to rule on stem cell patents
Monday 10 October 2011
The European Court of Justice is scheduled to issue a judgment on 18 October 2011 in a case concerning the patentability of technology based on the use of human embryonic stem cells. The case involves a German researcher, Oliver Brüstle.
Location
Luxembourg
Scientists derive stem cells from cloned embryo
Friday 7 October 2011
A team of US scientists has used cloning technology to create embryos from the skin cells of diabetic patients, and then derived stem cells from these embryos. This is thought to be the first such procedure using patient-specific cells.
Location
United States
Stem-cell trial starts in the UK
Monday 12 September 2011
Mesoblast Ltd of Australia has received clearance to start a Phase 2 trial of a new allogeneic stem-cell therapy in patients suffering acute heart attacks. The UK’s King’s College Hospital NHS Foundation Trust is one of the study sites.
Location
United Kingdom
F-Star signs discovery pact with Merck Serono
Wednesday 7 September 2011
F-Star GmbH of Vienna will discover engineered antibodies for three inflammatory targets supplied by Merck Serono SA of Geneva in a contract that is potentially worth €492 million plus tiered royalties on product sales.
Location
Austria
Direct cellular reprogramming reported
Wednesday 31 August 2011
Researchers at the Harvard Stem Cell Institute have reported the reprogramming of adult mouse skin cells directly into a type of motor neuron by a method which they say is more efficient than the process for creating induced pluripotent stem cells.
Location
United States
EU project to study cell and gene therapy in heart disease
Thursday 14 July 2011
The European Commission has awarded €5.3 million over four years to a consortium led by Ark Therapeutics Group Plc to investigate the possible use of gene and cell therapy, along with stents, in the treatment of coronary heart disease.
Location
United Kingdom
Roslin Cells and Pfizer sign stem-cell agreement
Thursday 14 July 2011
Roslin Cells Ltd has reached an agreement with Pfizer Inc giving the US multinational access to its pluripotent stem cell lines with a view to assessing their potential for specific clinical therapies. Financial terms were not disclosed.
Location
United States
Trials using hESC technology under way in US
Thursday 14 July 2011
Advanced Cell Technology Inc has announced the dosing of the first patients in each of its two Phase 1/2 clinical trials for eye disorders using retinal pigment epithelial cells derived from human embryonic stem cells (hESCs).
Location
United States
New method for creating iPS cells
Thursday 30 June 2011
A new method for deriving induced pluripotent stem cells (iPSCs) from blood samples has been described in the journal, Blood. According to the authors, the approach could provide a new source of patient-specific cells for disease research and drug discovery.
Location
United States
Sanofi takes option on hearing technology
Friday 17 June 2011
Sanofi SA has entered into a two-year research collaboration with a small Netherlands-based company, Audion Therapeutics BV, to develop potential treatments for hearing loss by targeting progenitor cells in the inner ear with small molecule compounds.
Location
Netherlands
Select a News Category
Recent Appointments
Steffen Thirstrup joins NDA Group
Monday June 10 2013
Tarquin Bennett-Coles joins Odgers Berndtson
Monday June 10 2013
Sandy Eisen becomes non-executive director at Phosphate Therapeutics
Thursday June 6 2013
Eric-Paul Paques to chair Grünenthal
Thursday June 6 2013
Charles DeCarli joins advisory board at DiaGenic
Thursday June 6 2013